Cargando…
Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells
Background: Despite recent improvements in therapy, the five-year survival rate for patients with advanced melanoma is poor, mainly due to the development of drug resistance. The aim of the present study was to investigate the mechanisms underlying this phenomenon, applying proteomics and structural...
Autores principales: | Tabolacci, Claudio, Giordano, Deborah, Rossi, Stefania, Cordella, Martina, D’Arcangelo, Daniela, Moschella, Federica, D’Atri, Stefania, Biffoni, Mauro, Facchiano, Angelo, Facchiano, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698468/ https://www.ncbi.nlm.nih.gov/pubmed/36431901 http://dx.doi.org/10.3390/molecules27227800 |
Ejemplares similares
-
Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals
por: Tabolacci, Claudio, et al.
Publicado: (2021) -
Nicotinamide inhibits melanoma in vitro and in vivo
por: Scatozza, Francesca, et al.
Publicado: (2020) -
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness
por: Rossi, Stefania, et al.
Publicado: (2018) -
PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach
por: D'Arcangelo, Daniela, et al.
Publicado: (2016) -
Targeting Melanoma-Initiating Cells by Caffeine: In Silico and In Vitro Approaches
por: Tabolacci, Claudio, et al.
Publicado: (2021)